According to the financial audit report of Vietnam’s Ernst and Young, at the end of 2009, Vien Dong Pharmaceutical JSC has charter capital of 119, 1 billions VND. The company has about 11,91 billions existing stocks on the concentration stock exchange market (transacting at Ho Chi Minh city stock exchange-HOSE), market capitalization ended 2009 was 1,131450 millions VND.  

About results of production and business, in 2009, Vien Dong Pharmaceutical JSC attained net revenue over 917, 8 billions VND equivalent to 43% of revenue increasing in comparison with 2008. The before-tax profit was over 134.47 billions VND (increased 335%).   

Other financial indicators are also attractive in comparison with listed companies in general and the other pharmaceutical, medical companies in particular. And net interest ratio attained 12%; 6% of ROA; 91% of ROE; specifically, Earning per share (EPS) attained 11,977 VND per share in 2009 (increasing 295% in comparison with the same in 2008). The existing P/E ratio of DVD is valuating at 8 times.  

In the fluctuating situation of stock exchange in the first transactions after a long Tet holiday, DVD shares still has good transactions, increase price continuously in sessions of the end February and early March, 2010 (ended transaction on 2/3, DVD increased more 4000 VND per share, had price at  101,000 VND per share. 

The price of DVD is attained show that the evaluation of analysts on development potential of DVA is proving. In the middle of January, 2010, the VnDirect securities company announced analysis report on Vien Dong pharmaceutical JSC and DVD code, including of the comment on price 94,500 VND per share (on 11/1/29190, P/E ratio (estimated, unaudited) of 7, 73 in 2009- the “quite cheap valuating” in comparison with market in general and other companies in the same sector. 

In other words, this comment shows that DVD has good development potential. At the time of reporting from VnDirect Securities Company, average P/E ratio on the market was about 14, 0 and 9, 59 of Pharmaceutical sector. Compare to announced audit results, P/E ratio at 8, 0 is lower than the average ratio in the market and pharmaceutical sector.  Before, the Tan Viet securities company had statement that “DVD price is fluctuating between 123,200 and 140,000 VND per share” and said that DVD is “a good choice to enlist investment portfolio. 

According to the analysts, the strength of Vien Dong Pharmaceutical JSC bases on three points, including pharmaceutical manufacturing operations by selling copyright of products; pharmaceutical production by researching and development; and having the leading delivery system in Vietnam and state that "DVD will have a higher profit rate in 2010 due to maintain low cost of sales from the early years."

Back to results of financial audit report ended 2009 has been announced by Vien Dong Pharmaceutical JSC, we may find that the company achieved revenue results and higher revenue growth (over 917.18 billion VND, revenue growth of 43%), good profit and  profit growth (after-tax profit reached 108.74 billion VND, profit growth at 335%) are results reflecting the process of building and improving Product portfolio to ensure higher margin profits; boosting up the marketing and expanding professional delivery network to all countries

Although 9, 76 of P / E ratio in 2010 of the DVD expected is relatively high, because at the late 2009 and early 2010, the company has doubled charter capital to restructure capital, meet capital requirements for the factory in Bac Ninh city and building GSP warehouses system, this investment has created immediately equivalent revenue and profit in 2010, but the analysts stated this is prerequisites for revenue and profit growth of DVD from 2011 onwards.

Some financial audited indicators of DVD: